The 36-month beta value for APLM is also noteworthy at 1.16. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for APLM is 66.39M, and at present, short sellers hold a 0.25% of that float. The average trading volume of APLM on November 22, 2024 was 27.50M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
APLM) stock’s latest price update
Apollomics Inc (NASDAQ: APLM) has experienced a rise in its stock price by 1.49 compared to its previous closing price of 0.10. However, the company has seen a gain of 6.88% in its stock price over the last five trading days. globenewswire.com reported 2024-09-04 that FOSTER CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced Company management will be presenting at the H.C. Wainwright 26th Annual Global Investment Conference taking place on September 9-11, 2024 virtually and in person at the Lotte New York Palace Hotel in New York, NY.
APLM’s Market Performance
Apollomics Inc (APLM) has seen a 6.88% rise in stock performance for the week, with a -23.11% decline in the past month and a -26.26% plunge in the past quarter. The volatility ratio for the week is 48.20%, and the volatility levels for the past 30 days are at 19.14% for APLM. The simple moving average for the past 20 days is -17.60% for APLM’s stock, with a -66.76% simple moving average for the past 200 days.
APLM Trading at -22.56% from the 50-Day Moving Average
After a stumble in the market that brought APLM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.67% of loss for the given period.
Volatility was left at 19.14%, however, over the last 30 days, the volatility rate increased by 48.20%, as shares sank -22.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.99% lower at present.
During the last 5 trading sessions, APLM rose by +10.64%, which changed the moving average for the period of 200-days by -85.14% in comparison to the 20-day moving average, which settled at $0.1246. In addition, Apollomics Inc saw -89.38% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APLM
Current profitability levels for the company are sitting at:
- -23.37 for the present operating margin
- 1.0 for the gross margin
The net margin for Apollomics Inc stands at -25.18. The total capital return value is set at -2.42. Equity return is now at value -149.31, with -107.81 for asset returns.
Based on Apollomics Inc (APLM), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -7.8.
Currently, EBITDA for the company is -171.75 million with net debt to EBITDA at 0.41. When we switch over and look at the enterprise to sales, we see a ratio of -4.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.25.
Conclusion
In summary, Apollomics Inc (APLM) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
